STOCKHOLDERS’ EQUITY (Details Narrative) - USD ($)	3 Months Ended		6 Months Ended		12 Months Ended
	Jun. 30, 2021	Jun. 30, 2020	Jun. 30, 2021	Jun. 30, 2020	Dec. 31, 2019	Dec. 31, 2020	Apr. 30, 2018
Class of Stock [Line Items]
Common Stock, Shares Authorized	300,000,000		300,000,000			300,000,000
Common Stock, Par or Stated Value Per Share	$ 0.0001		$ 0.0001			$ 0.0001
Common Stock, Shares, Outstanding	73,760,595		73,760,595			46,986,794
Acquisition expenses	$ 0	$ (18,488)	$ 0	$ 1,862,638
Stock reserved for issuance	272,654,379		272,654,379
Series A Preferred Stock Conversion [Member]
Class of Stock [Line Items]
Stock reserved for issuance	72,725,000		72,725,000
Series B Preferred Stock Conversion [Member]
Class of Stock [Line Items]
Stock reserved for issuance	475,000		475,000
Convertible Note Conversions [Member]
Class of Stock [Line Items]
Stock reserved for issuance	197,131,851		197,131,851
Warrant Exercises [Member]
Class of Stock [Line Items]
Stock reserved for issuance	2,322,528		2,322,528
Alternative Medical Solutions [Member]
Class of Stock [Line Items]
Acquisition expenses					$ 5,800,000
Series A Preferred Stock [Member]
Class of Stock [Line Items]
Preferred shares, issued	58,180		58,180			60,000	60,000
Preferred shares, par value	$ 1.00		$ 1.00			$ 1.00
Convertible stock terms of conversion			Each Series A Preferred Share is convertible into 1,250 shares of Common Stock
Preferred shares, outstanding	58,180		58,180			60,000